Photys Therapeutics

Photys Therapeutics' patented bifunctional small molecule platform enables fine-tuned control of post-translational protein modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys Therapeutics is advancing a proprietary new class of bifunctional drugs that direct and repair protein phosphorylation to treat a range of diseases, including cancer, immunological, metabolic, and rare diseases.